Anaptysbio Inc (ANAB)

EBITDA Growth

181.77%

Quarterly · Period ending:

ANAB logo

ANAB EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported181.77%
ANAB Quarterly EBITDA YoY % (58.50% → 181.77%)
High-resolution chart · PNG

ANAB ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anaptysbio Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
181.7668%
-52.1729%
1,939.5166%
327.0395%
47.6284%
44.2968%
88.8687%
47.8334%
-0.5817%
5.8791%
-58.7962%
-20.5474%
-33.6397%
-27.5658%
33.0327%
-346.59%
-7,435.6742%
-70.9059%
-195.1554%
74.4068%
101.6929%
-122.0882%
269.4159%
23.6966%
11.3336%
62.5058%
-19.324%
-98.5453%
-80.7974%
-48.5632%
-162.8971%
-80.0163%
-497.9034%
-32.9413%
-44.205%
-813.0712%
-187.8303%
-1,431.8436%
-35.7451%
-50.56%
1,792.4242%
-280.8511%
-653.322%
-117.6753%
-91.0811%
58.4989%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.